Corpus Intelligence IC Memo — WASHINGTON COUNTY HOSPITAL 2026-04-26 15:54 UTC
IC Memo — WASHINGTON COUNTY HOSPITAL
Investment Committee Memorandum | AL | 15 beds | Grade C | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WASHINGTON COUNTY HOSPITAL

CCN 011300 | WASHINGTON, AL | 15 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

WASHINGTON COUNTY HOSPITAL is a 15-bed rural/critical access in WASHINGTON, AL with $16.2M in net patient revenue and a -6.6% operating margin. The hospital serves a payer mix of 49.5% Medicare, 15.8% Medicaid, and 34.6% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -6.6% to 0.8% (+736bps).

Net Revenue HCRIS$16.2M
Current EBITDA COMPUTED$-1.1M
Operating Margin COMPUTED-6.6%
Occupancy HCRIS34.7%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS76.8%
Distress Probability ML60.5%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
17
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -6.6% places it above the state median. Among 17 size-comparable peers (8-30 beds), the median margin is -24.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-30), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WASHINGTON COUNTY HOSPITAL (Target)AL15$16.2M-6.6%
ST. VINCENTS CHILTONAL26$29.1M9.2%
ST. VINCENTS BLOUNTAL25$25.2M-33.1%
NORTHWEST MEDICAL CENTERAL28$23.8M-12.1%
BIBB MEDICAL CENTERAL25$19.8M-20.1%
CHOCTAW GENERAL HOSPITALAL25$17.7M-2.8%
MEDICAL CENTER BARBOURAL30$17.6M-34.1%
TANNER MEDICAL CENTER ALABAMA AL15$15.0M-12.0%
BULLOCK COUNTY HOSPITALAL29$13.9M-24.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$340K+210bp18mo
Cost to Collect4.5%2.5%$324K+200bp12mo
Denial Rate Reduction12.0%6.5%$321K+198bp12mo
A/R Days Reduction5200.0%3800.0%$197K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$340K
Cost to Collect
$324K
Denial Rate Reduction
$321K
A/R Days Reduction
$197K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.2M
Current EBITDA$-1.1M
+ RCM Uplift+$1.2M
Pro Forma EBITDA$130K
Current Margin-6.6%
Pro Forma Margin0.8%
WC Released (1x)$622K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.6M$4.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.6M$4.9M0.00x-100.0%
Bull Case9.0x11.0x$-1.5M$8.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.5M$8.6M0.00x-100.0%
Bear Case11.0x10.0x$-1.8M$-515K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.8M$-1.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 34.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 60.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 8-30 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-50.0% / P50=-24.8% / P75=-12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.